Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Sher

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinomaPaul J Kelly, Stephanie E Weiss, David J Sher, et al.
Radiation Oncology (London, England)|January 30, 2019
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysisCorey C Foster, David J Sher, Chad G Rusthoven, et al.
Oral Oncology|March 12, 2014
Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparingVirag Dandekar, Tiffany Morgan, Julius Turian, et al.
Oral Oncology|December 12, 2017
Risk of contralateral nodal failure following ipsilateral IMRT for node-positive tonsillar cancerSujana Gottumukkala, Nhat-Long Pham, Baran Sumer, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 2, 2016
Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus EraDavid J Sher, Lucien Nedzi, Saad Khan, et al.
Practical Radiation Oncology|September 7, 2014
Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapyShalini Garg, Benjamin T Gielda, Krystyna Kiel, et al.
Journal of Neuro-Oncology|August 25, 2017
Association between hospital volume and receipt of treatment and survival in patients with glioblastomaMatthew Koshy, David J Sher, Michael Spiotto, et al.
BMC Cancer|May 12, 2026
Involved nodal versus elective neck radiotherapy (INVERT) for head and neck squamous cell carcinoma: a prospective phase II randomized controlled trial protocolSympascho Young, Dominic H Moon, Jing Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2010
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapyJonathan D Schoenfeld, David J Sher, Charles M Norris, et al.
JCO Clinical Cancer Informatics|March 25, 2022
Pilot Study of a Wearable Activity Monitor During Head and Neck Radiotherapy to Predict Clinical OutcomesDavid J Sher, Sepeadeh Radpour, Jennifer L Shah, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2010
Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinomaPaul J Kelly, Stephanie E Weiss, David J Sher, et al.
Radiation Oncology (London, England)|January 30, 2019
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysisCorey C Foster, David J Sher, Chad G Rusthoven, et al.
Oral Oncology|March 12, 2014
Patterns-of-failure after helical tomotherapy-based chemoradiotherapy for head and neck cancer: implications for CTV margin, elective nodal dose and bilateral parotid sparingVirag Dandekar, Tiffany Morgan, Julius Turian, et al.
Oral Oncology|December 12, 2017
Risk of contralateral nodal failure following ipsilateral IMRT for node-positive tonsillar cancerSujana Gottumukkala, Nhat-Long Pham, Baran Sumer, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 2, 2016
Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus EraDavid J Sher, Lucien Nedzi, Saad Khan, et al.
Practical Radiation Oncology|September 7, 2014
Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapyShalini Garg, Benjamin T Gielda, Krystyna Kiel, et al.
Journal of Neuro-Oncology|August 25, 2017
Association between hospital volume and receipt of treatment and survival in patients with glioblastomaMatthew Koshy, David J Sher, Michael Spiotto, et al.
BMC Cancer|May 12, 2026
Involved nodal versus elective neck radiotherapy (INVERT) for head and neck squamous cell carcinoma: a prospective phase II randomized controlled trial protocolSympascho Young, Dominic H Moon, Jing Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2010
Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapyJonathan D Schoenfeld, David J Sher, Charles M Norris, et al.
JCO Clinical Cancer Informatics|March 25, 2022
Pilot Study of a Wearable Activity Monitor During Head and Neck Radiotherapy to Predict Clinical OutcomesDavid J Sher, Sepeadeh Radpour, Jennifer L Shah, et al.
Pageof 16